Allerkast Syrup
By Allerkast
Rx
30ml Syrup in a Bottle

Composition
Levocetirizine(5mg) + Montelukast(10mg)

Manufacturer - Lupin Ltd
Lupin Ltd, 3rd floor Kalpataru Inspire, Off. W E Highway, Santacruz (East), Mumbai 400 055. India

Expires on or after
August, 2025

liver
When it comes to ensuring safety while using Allerkast Syrup, it's crucial to take caution especially if you have severe liver disease. In such cases, it is advisable to consult with your doctor as a dose adjustment may be necessary. The available information on the use of Allerkast Syrup in individuals with severe liver disease is limited, highlighting the importance of seeking medical advice before starting the medication. However, for patients with mild to moderate liver disease, no dose adjustment is typically required. It's always best to prioritize your liver health and communicate openly with your healthcare provider to ensure the safe and effective use of Allerkast Syrup.

kidney
Caution should be taken when using Allerkast Syrup in patients with kidney disease. Dose adjustment may be necessary, and it is advised to consult your doctor before use. This syrup is not recommended for individuals with severe kidney disease.

alcohol
When taking Allerkast Syrup, be cautious with alcohol consumption and consult your doctor.

driving
When using Allerkast Syrup, be cautious while driving as it may reduce alertness, cause vision problems, or lead to drowsiness and dizziness. Refrain from driving if experiencing these symptoms.

pregnancy
During pregnancy, Allerkast Syrup is generally safe to use. Animal studies indicate minimal harmful effects to the baby, but human studies are limited.

breastfeeding
Caution should be taken when breastfeeding while using Allerkast Syrup as it is considered unsafe. Research indicates potential toxicity to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹20.58
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 01-Oct-2024